Crossmark

Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis

Published Online: 2016-06-13

Published Print: 2016-12

Authors

Zhang, Yan

Li, Lixiang

Guo, Chuanguo

Mu, Dan

Feng, Bingcheng

Zuo, Xiuli

Li, Yanqing
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81370495, 81330012)
License Information

License valid from 2016-06-13

Document is current